Actuate Therapeutics Inc

NASDAQ: ACTU · Real-Time Price · USD
8.00
-0.22 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
8.12
1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

Actuate Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
Net Income
-27.29M -24.74M -20.16M
Depreciation & Amortization
n/a n/a n/a
Stock-Based Compensation
2M 423.54K 654.07K
Other Working Capital
2.6M 1.28M 1.15M
Other Non-Cash Items
2.35M 123.46K -20.38K
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
1.1M 2.57M 1.73M
Operating Cash Flow
-21.84M -21.63M -17.79M
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
n/a n/a n/a
Debt Repayment
5.5M n/a n/a
Common Stock Repurchased
485.17K n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-1.93M n/a n/a
Financial Cash Flow
27.53M 4.13M 19.26M
Net Cash Flow
5.68M -17.49M 1.46M
Free Cash Flow
-21.84M -21.63M -17.79M